Falsified Medical Product Alert N°8/2021
Combiart (artemether and lumefantrine): falsified product alert
WHO issued this alert on one falsified batch of Combiart, an antimalarial, reported to WHO in November 2021. It was found at patient level outside authorised supply chains. Laboratory analysis did not detect artemether or lumefantrine. The carton expiry is 10/2021 while the blister expiry is 10/2022.1
- Issued
- 21 December 2021
- Issued by
- World Health Organization
- Name stated on packaging
- Packaging bears the Combiart brand, with Tanzania Reg No TZ13H260 on the blister. WHO did not name the company shown on the falsified packs.
- Genuine manufacturer's statement
- WHO said the genuine manufacturer of Combiart confirmed that the product listed in the alert is falsified.
- Countries where detected
- Chad, Côte d'Ivoire, Mali
Batches named in the alert
7225119
Advice as stated
Do not use the listed products. Obtain medicines only from authorised or licensed suppliers and check their authenticity and condition. Report adverse events or suspected falsification to the national regulatory authority or pharmacovigilance centre.
Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.
Sources
- World Health Organization, Medical Product Alert N°8/2021: Falsified Combiart (21 December 2021)